The Nigerian government has approved a new malaria vaccine from Oxford University, becoming the second country after Ghana in the world to grant such approval.
The vaccine- R21/Matrix-M, is developed by the University of Oxford and manufactured by the Serum Institute of India.
The Director General of Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC), Mojisola Adeyeye, announced the development on Monday in Abuja.